Institutional Ownership
Lipocine Inc New
CUSIP 53630X203COM NEWLPCNQ1 2026
13D / 13G Filings
2
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
9.5%
Max % of class reported
Institutional Holders
44
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
2 filings · latest Feb 17, 2026
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ikarian Capital, LLC | 508.6K | $4.06M |
| 2 | Squadron Capital Management LLC | 450.0K | $3.60M |
| 3 | Eversept Partners, LP | 295.0K | $2.36M |
| 4 | Rosalind Advisors, Inc. | 221.6K | $1.77M |
| 5 | Aigh Capital Management LLC | 200.0K | $1.60M |
| 6 | Stempoint Capital LP | 160.4K | $1.28M |
| 7 | Boothbay Fund Management, LLC | 140.5K | $1.12M |
| 8 | Seven Fleet Capital Management LP | 124.9K | $998.3K |
| 9 | Birchview Capital, LP | 111.8K | $893.2K |
| 10 | Blackrock, Inc. | 89.3K | $713.3K |